128 related articles for article (PubMed ID: 8684513)
1. [Long-term treatment with 7S immunoglobulins in myasthenia gravis. Preliminary clinical results].
Bamberg C; Janzen RW; Szabados M
Nervenarzt; 1996 Apr; 67(4):327-32. PubMed ID: 8684513
[TBL] [Abstract][Full Text] [Related]
2. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
3. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial.
Gajdos P; Tranchant C; Clair B; Bolgert F; Eymard B; Stojkovic T; Attarian S; Chevret S;
Arch Neurol; 2005 Nov; 62(11):1689-93. PubMed ID: 16286541
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment of myasthenia gravis with immunoadsorption.
Haas M; Mayr N; Zeitlhofer J; Goldammer A; Derfler K
J Clin Apher; 2002; 17(2):84-7. PubMed ID: 12210711
[TBL] [Abstract][Full Text] [Related]
5. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.
Tsukaguchi M; Shimamura M; Ikeda K; Urai Y; Sasaki I; Deguchi K; Touge T; Takeuchi H; Kuriyama S
J Neurol Sci; 2005 Apr; 231(1-2):85-8. PubMed ID: 15792826
[TBL] [Abstract][Full Text] [Related]
6. Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
Wakata N; Nemoto H; Sugimoto H; Nomoto N; Konno S; Hayashi N; Araki Y; Nakazato A
Clin Neurol Neurosurg; 2004 Mar; 106(2):139-41. PubMed ID: 15003307
[TBL] [Abstract][Full Text] [Related]
7. High-dose intravenous immunoglobulin in the management of myasthenia gravis.
Arsura EL; Bick A; Brunner NG; Namba T; Grob D
Arch Intern Med; 1986 Jul; 146(7):1365-8. PubMed ID: 3718134
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.
Gajdos P; Chevret S; Clair B; Tranchant C; Chastang C
Ann Neurol; 1997 Jun; 41(6):789-96. PubMed ID: 9189040
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of tacrolimus on myasthenia gravis with thymoma.
Mitsui T; Kunishige M; Ichimiya M; Shichijo K; Endo I; Matsumoto T
Neurologist; 2007 Mar; 13(2):83-6. PubMed ID: 17351528
[TBL] [Abstract][Full Text] [Related]
11. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.
Takahashi H; Kawaguchi N; Nemoto Y; Hattori T
J Neurol Sci; 2006 Sep; 247(2):239-41. PubMed ID: 16876198
[TBL] [Abstract][Full Text] [Related]
12. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil in the therapy of severe myasthenia gravis.
Schneider C; Gold R; Reiners K; Toyka KV
Eur Neurol; 2001; 46(2):79-82. PubMed ID: 11528156
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis.
Zeitler H; Ulrich-Merzenich G; Hoffmann L; Kornblum C; Schmidt S; Vetter H; Walger P
Artif Organs; 2006 Aug; 30(8):597-605. PubMed ID: 16911313
[TBL] [Abstract][Full Text] [Related]
15. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
[TBL] [Abstract][Full Text] [Related]
16. Plasmapheresis therapy in myasthenia gravis.
Dau PC
Muscle Nerve; 1980; 3(6):468-82. PubMed ID: 7453714
[TBL] [Abstract][Full Text] [Related]
17. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of myasthenia gravis with intravenous immunoglobulin G (IVIG)].
Lavrnić DB; Stojanović V; Marinković Z; Pavlović S; Vidaković A; Apostolski S
Srp Arh Celok Lek; 1995; 123(5-6):146-8. PubMed ID: 17974459
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis.
Pompeo E; Tacconi F; Massa R; Mineo D; Nahmias S; Mineo TC
Eur J Cardiothorac Surg; 2009 Jul; 36(1):164-9. PubMed ID: 19339195
[TBL] [Abstract][Full Text] [Related]
20. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
Köhler W; Bucka C; Klingel R
J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
